Stay updated on Nivolumab for Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab for Esophageal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 removed, indicating a site version update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedPublication notes were clarified to indicate that publications are automatically filled from PubMed and may not be about the study. The revision information was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded location 'Tainan, Taiwan, 704' and removed 'Tainan City, Taiwan, 704' from the study locations.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page shows minor layout and timestamp updates. Core study data such as eligibility criteria, primary outcomes, and enrollment remain unchanged.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a government-funding operating-status notice and link to NIH/cc information; page now shows Revision: v3.2.0. - Removed the resource topic: Carcinoma of esophagus (Genetic and Rare Diseases Information Center).SummaryDifference4%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.